[Updated cytokine therapy of erectile dysfunction]

Area of Science:

• Urology
• Immunology
• Regenerative Medicine

Background:

• Erectile dysfunction (ED) pathogenesis involves complex biological pathways.
• Current ED treatments like PDE-5 inhibitors have limitations.
• Cytokines represent a novel therapeutic avenue for ED.

Purpose of the Study:

• To explore the multifaceted roles of cytokines in ED.
• To evaluate the potential of specific cytokines as targeted ED therapies.
• To identify limitations and future research directions for cytokine-based ED treatment.

Main Methods:

• Review of existing literature on cytokine involvement in ED.
• Analysis of cytokine functions related to vascular, neural, and smooth muscle health.
• Assessment of studies utilizing cytokine-based interventions, primarily in animal models.

Main Results:

• Four cytokine types are linked to ED pathogenesis and treatment: pro-angiogenic, pro-nerve regeneration, smooth muscle protective, and inflammation-related.
• Cytokines offer targeted mechanisms for improving erectile function, distinct from PDE-5 inhibitors.
• Specific cytokines like VEGF, IGF-1, BDNF, and NGF demonstrated efficacy in ED rat models.

Conclusions:

• Cytokines hold significant therapeutic potential for ED due to their targeted actions.
• Current evidence, largely from rat models, necessitates larger-scale studies and larger animal experiments.
• Further research is crucial to validate the clinical efficacy and safety of cytokines for ED treatment.